BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7960577)

  • 21. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
    Welch DR; Aeed PA; Earhart RH; McClure SA
    Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
    Welch DR; Fabra A; Nakajima M
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7678-82. PubMed ID: 2217201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.
    McGary CT; Miele ME; Welch DR
    Am J Pathol; 1995 Dec; 147(6):1668-81. PubMed ID: 7495292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo.
    Goya L; Alexander DB; Webster MK; Kern FG; Guzman RC; Nandi S; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1816-22. PubMed ID: 8467500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of apoptosis by EGF receptor in rat mammary adenocarcinoma cells coincides with enhanced spontaneous tumour metastasis.
    Kaufmann AM; Lichtner RB; Schirrmacher V; Khazaie K
    Oncogene; 1996 Dec; 13(11):2349-58. PubMed ID: 8957076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
    Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
    Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
    Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand mediated activation of ectopic EGF receptor promotes matrix protein adhesion and lung colonization of rat mammary adenocarcinoma cells.
    Lichtner RB; Kaufmann AM; Kittmann A; Rohde-Schulz B; Walter J; Williams L; Ullrich A; Schirrmacher V; Khazaie K
    Oncogene; 1995 May; 10(9):1823-32. PubMed ID: 7753557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma.
    Saulnier R; Bhardwaj B; Klassen J; Leopold D; Rahimi N; Tremblay E; Mosher D; Elliott B
    Exp Cell Res; 1996 Feb; 222(2):360-9. PubMed ID: 8598224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
    North SM; Steck PA; Nicolson GL
    Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of a Mr approximately 66,000 lung-derived (paracrine) growth factor that preferentially stimulates the in vitro proliferation of lung-metastasizing tumor cells.
    Cavanaugh PG; Nicolson GL
    J Cell Biochem; 1990 Jun; 43(2):127-38. PubMed ID: 2166061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials.
    Inoue T; Cavanaugh PG; Steck PA; BrĂ¼nner N; Nicolson GL
    J Cell Physiol; 1993 Jul; 156(1):212-7. PubMed ID: 8314858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
    Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
    Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET.
    Lynch MJ; Pelosi L; Carboni JM; Merwin J; Coleman K; Wang RC; Lin PF; Henry DL; Brattain MG
    Cancer Res; 1993 Sep; 53(17):4041-7. PubMed ID: 8358733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro.
    Yokozeki M; Moriyama K; Shimokawa H; Kuroda T
    Exp Cell Res; 1997 Mar; 231(2):328-36. PubMed ID: 9087174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.